Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Baylor College of Medicine, Houston
Researchers' work adds to breast cancer body of knowledge
November 4th, 2005
Breast cancer data are the focus of recent research from the United States and United Kingdom. Study 1: Hormone receptor status of primary breast cancer (PBC) did not predict the hormone receptor status of the contralateral breast cancer (CBC). Researchers in the United States conducted a study "to determine whether the hormone receptor status of PBC is predictive of the hormone receptor status of the subsequent CBC. We identified patients in our database with known estrogen receptor (ER; n=193) and/or progesterone receptor (PgR; n=178) status in their PBC and in their subsequent CBC. One hundred twenty-six of these patients had received no adjuvant...
Source: Biotech Law Weekly (2005-11-04)
|
